Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Klein

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Blood|May 1, 2010
Positioning NK-kappaB in multiple myelomaBernard Klein
British Journal of Haematology|October 16, 2012
Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedsideMounia S Braza, Bernard Klein
Cell Cycle (Georgetown, Tex.)|May 28, 2013
Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphomaCaroline Bret, Bernard Klein, Jérôme Moreaux
Biochemical and Biophysical Research Communications|January 6, 2009
MMSET is overexpressed in cancers: link with tumor aggressivenessAlboukadel Kassambara, Bernard Klein, Jérome Moreaux
Oncotarget|March 14, 2013
Gene expression-based risk score in diffuse large B-cell lymphomaCaroline Bret, Bernard Klein, Jérôme Moreaux
JAMA Internal Medicine|April 5, 2021
Tocilizumab in Treatment for Patients With COVID-19Jean-François Rossi, Hao-Chun Chiang, Bernard Klein
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironmentBernard Klein, Anja Seckinger, Thomas Moehler, et al.
Bioinformatics (Oxford, England)|March 16, 2013
Modeling risk stratification in human cancerThierry Rème, Dirk Hose, Charles Theillet, et al.
Biochemical and Biophysical Research Communications|November 13, 2012
STEAP1 is overexpressed in cancers: a promising therapeutic targetJerome Moreaux, Alboukadel Kassambara, Dirk Hose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidenceMohit Trikha, Robert Corringham, Bernard Klein, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Blood|May 1, 2010
Positioning NK-kappaB in multiple myelomaBernard Klein
British Journal of Haematology|October 16, 2012
Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedsideMounia S Braza, Bernard Klein
Cell Cycle (Georgetown, Tex.)|May 28, 2013
Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphomaCaroline Bret, Bernard Klein, Jérôme Moreaux
Biochemical and Biophysical Research Communications|January 6, 2009
MMSET is overexpressed in cancers: link with tumor aggressivenessAlboukadel Kassambara, Bernard Klein, Jérome Moreaux
Oncotarget|March 14, 2013
Gene expression-based risk score in diffuse large B-cell lymphomaCaroline Bret, Bernard Klein, Jérôme Moreaux
JAMA Internal Medicine|April 5, 2021
Tocilizumab in Treatment for Patients With COVID-19Jean-François Rossi, Hao-Chun Chiang, Bernard Klein
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironmentBernard Klein, Anja Seckinger, Thomas Moehler, et al.
Bioinformatics (Oxford, England)|March 16, 2013
Modeling risk stratification in human cancerThierry Rème, Dirk Hose, Charles Theillet, et al.
Biochemical and Biophysical Research Communications|November 13, 2012
STEAP1 is overexpressed in cancers: a promising therapeutic targetJerome Moreaux, Alboukadel Kassambara, Dirk Hose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidenceMohit Trikha, Robert Corringham, Bernard Klein, et al.
Pageof 13